These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 849078)

  • 1. Neurochemical properties of 3,3-dimethyl-1-[3-(methylamino) propyl]-1-phenylindan HCl (LU 3-049) and selected tricyclic antidepressants.
    Salama AI; Goldberg ME
    Arch Int Pharmacodyn Ther; 1977 Feb; 225(2):317-29. PubMed ID: 849078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Correlation of presynaptic components (uptake--release) in antidepressants].
    Dolzhenko AT
    Farmakol Toksikol; 1984; 47(5):22-5. PubMed ID: 6094236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurochemical characterization of a new potent and selective serotonin uptake inhibitor: Lu 10-171.
    Hyttel J
    Psychopharmacology (Berl); 1977 Mar; 51(3):225-33. PubMed ID: 403537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potentiation of responses to adrenergic nerve stimulation in isolated rat atria during chronic tricyclic antidepressant administration.
    Crews FT; Smith CB
    J Pharmacol Exp Ther; 1980 Oct; 215(1):143-9. PubMed ID: 6256516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of 3-(p-trifluoromethylphenoxy). N. N. methyl-3-phenylpropylamine on the depletion of brain serotonin by 4-chloroamphetamine.
    Fuller RW; Perry KW; Molloy BB
    J Pharmacol Exp Ther; 1975 Jun; 193(3):793-803. PubMed ID: 1151729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hydroxylated metabolites of tricyclic antidepressants: preclinical assessment of activity.
    Potter WZ; Calil HM; Manian AA; Zavadil AP; Goodwin FK
    Biol Psychiatry; 1979 Aug; 14(4):601-13. PubMed ID: 486616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Substituted amphetamine derivatives. I. Effect on uptake and release of biogenic monoamines and on monoamine oxidase in the mouse brain.
    Ross SB; Ogren SO; Renyi AL
    Acta Pharmacol Toxicol (Copenh); 1977 Oct; 41(4):337-52. PubMed ID: 579062
    [No Abstract]   [Full Text] [Related]  

  • 8. Influence of the antidepressant binodaline on biogenic amine uptake and brain levels in the rat.
    Benfield DP; Luscombe DK
    Arzneimittelforschung; 1983; 33(6):847-50. PubMed ID: 6684438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of mianserin, a new antidepressant, on the in vitro and in vivo uptake of monoamines.
    Goodlet I; Mireylees SE; Sugrue MF
    Br J Pharmacol; 1977 Oct; 61(2):307-13. PubMed ID: 922259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The phenyl rings of tricyclic antidepressants and related compounds as determinants of the potency of inhibition of the amine pumps in adrenergic neurons of the rabbit aorta and in rat cortical synaptosomes.
    Maxwell RA; Ferris RM; Burcsu J; Woodward EC; Tang D; Williard K
    J Pharmacol Exp Ther; 1974 Dec; 191(3):418-30. PubMed ID: 4427288
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of clomipramine and other tricyclic antidepressants on biogenic amine uptake and turnover.
    Waldmeier PC; Baumann P; Greengrass PM; Maître L
    Postgrad Med J; 1976; 52(3 suppl):33-9. PubMed ID: 785423
    [No Abstract]   [Full Text] [Related]  

  • 12. Neurochemical profile of Lu 19-005, a potent inhibitor of uptake of dopamine, noradrenaline, and serotonin.
    Hyttel J; Larsen JJ
    J Neurochem; 1985 May; 44(5):1615-22. PubMed ID: 2580950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological and biochemical studies on a new compound, 2-(7-indeyloxymethyl)morpholine hydrochloride (YM-08054-1), and its derivatives with potential antidepressant properties.
    Tachikawa S; Harada M; Maeno H
    Arch Int Pharmacodyn Ther; 1979 Mar; 238(1):81-95. PubMed ID: 485706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new selective inhibitor for uptake of serotonin into synaptosomes of rat brain: 3-(p-trifluoromethylphenoxy). N-methyl-3-phenylpropylamine.
    Wong DT; Bymaster FP; Horng JS; Molloy BB
    J Pharmacol Exp Ther; 1975 Jun; 193(3):804-11. PubMed ID: 1151730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Inhibition of noradrenaline deamination by antidepressants].
    Moskvitina TA; Gankina EM; Val'dman AV
    Biull Eksp Biol Med; 1986 Jul; 102(7):44-6. PubMed ID: 3730591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacology of lortalamine, a new potent non-tricyclic antidepressant.
    Depin JC; Betbeder-Matibet A; Bonhomme Y; Muller AJ; Berthelon JJ
    Arzneimittelforschung; 1985; 35(11):1655-62. PubMed ID: 4091869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of antidepressants with different chemical structures on the uptake and release of norepinephrine in sections of the rat cerebral cortex].
    Dolzhenko AT
    Biull Eksp Biol Med; 1982 Mar; 93(3):29-31. PubMed ID: 6284275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Monoamines and the pharmacological effects of tricyclic antidepressive agents].
    Garattini S; Bonaccorsi A; Jori A; Samanin R
    Rev Neurol (Paris); 1972 Aug; 127(2):265-92. PubMed ID: 4603688
    [No Abstract]   [Full Text] [Related]  

  • 19. Inhibition of in vitro amine uptake into rat brain synaptosomes after in vivo administration of antidepressants.
    Manias B; Taylor DA
    Eur J Pharmacol; 1983 Nov; 95(3-4):305-9. PubMed ID: 6653676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of Org 6582, chlorimipramine and desmethylimipramine on the depletion of biogenic amines from the rat brain in vivo.
    Kafoe WF; Leonard BE
    Biochem Pharmacol; 1977 Jun; 26(11):1083-4. PubMed ID: 880260
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.